Comparison between Beta Drugs IPO and Shree Ganesh Remedies IPO.
Beta Drugs IPO is a SME Fixed Price IPO proposed to list at NSE SME while Shree Ganesh Remedies IPO is a SME Fixed Price proposed to list at BSE SME.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Pantomath Capital Advisors Pvt.Ltd. | Fedex Securities Pvt.Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Pantomath Stock Brokers Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Beta Drugs IPO is up to ₹18.41 Cr whereas the issue size of the Shree Ganesh Remedies IPO is up to ₹8.10 Cr. The final issue price of Beta Drugs IPO is ₹85.00 per share and of Shree Ganesh Remedies IPO is ₹36.00 per share.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹85.00 per share | ₹36.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | 21,66,400 shares | 22,50,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.41 Cr | up to ₹8.10 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 21,66,400 shares | 22,50,000 shares |
| Issue Size Total (Amount) | up to ₹18.41 Cr | up to ₹8.10 Cr |
Beta Drugs IPO opens on Sep 29, 2017, while Shree Ganesh Remedies IPO opens on Sep 28, 2017. The closing date of Beta Drugs IPO and Shree Ganesh Remedies IPO is Oct 04, 2017, and Oct 05, 2017, respectively.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 29, 2017 | Sep 28, 2017 |
| Issue Close | Oct 04, 2017 | Oct 05, 2017 |
| Basis Of Allotment (Tentative) | Oct 10, 2017 | |
| Initiation of Refunds (Tentative) | Oct 11, 2017 | |
| Credit of Share (Tentative) | Oct 12, 2017 | |
| Listing date (Tentative) | Oct 12, 2017 | Oct 13, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Beta Drugs IPO P/E ratio is , as compared to Shree Ganesh Remedies IPO P/E ratio of .
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Financials | ||
| Promoter Shareholding (Pre-Issue) | ||
| Promoter Shareholding (Post-Issue) | ||
| P/E Ratio | ||
| Market Cap | ||
| ROE | ||
| ROCE | ||
| Debt/Equity | ||
| EPS | ||
| RoNW |
In the Beta Drugs IPO Retail Individual Investors (RII) are offered 10,83,200 shares while in Shree Ganesh Remedies IPO retail investors are offered 10,83,200 shares. Qualified Institutional Buyers (QIB) are offered in Beta Drugs IPO and in Shree Ganesh Remedies IPO.
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 1,29,600 shares | 1,26,000 shares |
| QIB | ||
| NII | 10,83,200 shares | 11,25,000 shares |
| RII | 10,83,200 shares | 11,25,000 shares |
| Employee | ||
| Others | ||
| Total | 21,66,400 shares | 22,50,000 shares |
Beta Drugs IPO subscribed in total, whereas Shree Ganesh Remedies IPO subscribed .
| Beta Drugs IPO | Shree Ganesh Remedies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | ||
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | ||
| Employee (times) | ||
| Other (times) | ||
| Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
